Dear Valued Visitor,

We have noticed that you are using an ad blocker software.

Although advertisements on the web pages may degrade your experience, our business certainly depends on them and we can only keep providing you high-quality research based articles as long as we can display ads on our pages.

To view this article, you can disable your ad blocker and refresh this page or simply login.

We only allow registered users to use ad blockers. You can sign up for free by clicking here or you can login if you are already a member.

N Fredric Eshelman


  • Director at Amplitude Healthcare Acquisition Corp (AMHCU), 2019-11-20
  • Director at Eyenovia Inc. (EYEN), 2019-08-20
  • Director at G1 Therapeutics Inc. (GTHX), 2019-06-14
  • Executive Chairman at Medicines Co (MDCO), 2018-06-04
  • Director at Valeant Pharmaceuticals International Inc. (VRX), 2018-05-03
  • Large Shareholder, Director at Furiex Pharmaceuticals Inc. (FURX), 2014-07-07
  • Executive Chairman at Pharmaceutical Product Development Inc (PPDI), 2011-12-06
Insider Trading: Purchases See All
Company Symbol Price Amount Relationship Remaining Holdings Date Form 4
EYEN $10.00 335,000 Large Shareholder, Director 1,273,428 2018-01-29 Filing
MDCO $26.65 100,000 Officer, Director 1,128,383 2017-12-08 Filing
MDCO $26.46 100,000 Officer, Director 1,028,383 2017-12-07 Filing
GTHX $19.73 250,000 Large Shareholder, Director 250,000 2017-11-13 Filing
GTHX $15.00 300,000 Large Shareholder, Director 3,439,151 2017-05-22 Filing